Literature DB >> 8811523

Twenty-four hour ambulatory gastric and duodenal pH profiles in cystic fibrosis: effect of duodenal hyperacidity on pancreatic enzyme function and fat absorption.

M Barraclough1, C J Taylor.   

Abstract

Overt steatorrhoea remains a problem for some patients with cystic fibrosis (CF) despite supraphysiological dosages of pancreatic enzymes. As pancreatin release and enzyme function is influenced by duodenal pH, we have used 24-h ambulatory pH measurements to assess the extent and duration of postprandial hyperacidity. Readings were obtained from the stomach and proximal duodenum in 16 CF patients (aged 6 months to 12 years) using a dual-channel antimony electrode. The fasting gastric and duodenal pH values were normal in all patients (mean pH values of 1.3, and 6.8, respectively). There was, however, a marked drop in duodenal pH in the first postprandial hour, which became more pronounced with successive meals. The total time that duodenal pH was < 5 varied from 15 to 90% of the recording (mean 57%). Overnight the duodenal pH returned to normal levels. A subgroup of five patients were studied before and after treatment with omeprazole, a potent inhibitor of gastric acid secretion. There were significant improvements in both weight gain and fat absorption. This study supports the hypothesis that the postprandial duodenal pH is excessively acid in patients with CF and may be an important element in the continuing fat malabsorption experienced by some patients. This malabsorption may limit the efficacy of the newer high-lipase pancreatic enzyme supplements and lead to delayed enzyme release, a possible factor in the recent reports of proximal colonic strictures.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811523     DOI: 10.1097/00005176-199607000-00009

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  12 in total

1.  Is fibrosing colonopathy an immune mediated disease?

Authors:  J Lee; W Ip; P Durie
Journal:  Arch Dis Child       Date:  1997-07       Impact factor: 3.791

Review 2.  Similarities and differences in gastrointestinal physiology between neonates and adults: a physiologically based pharmacokinetic modeling perspective.

Authors:  Guo Yu; Qing-Shan Zheng; Guo-Fu Li
Journal:  AAPS J       Date:  2014-09-03       Impact factor: 4.009

3.  Iron supplementation does not worsen respiratory health or alter the sputum microbiome in cystic fibrosis.

Authors:  Alex H Gifford; Diana M Alexandru; Zhigang Li; Dana B Dorman; Lisa A Moulton; Katherine E Price; Thomas H Hampton; Mitchell L Sogin; Jonathan B Zuckerman; H Worth Parker; Bruce A Stanton; George A O'Toole
Journal:  J Cyst Fibros       Date:  2013-12-13       Impact factor: 5.482

4.  Gastric emptying and intestinal transit of pancreatic enzyme supplements in cystic fibrosis.

Authors:  C J Taylor; P G Hillel; S Ghosal; M Frier; S Senior; W B Tindale; N Read
Journal:  Arch Dis Child       Date:  1999-02       Impact factor: 3.791

5.  Impaired mucosal barrier function in the small intestine of the cystic fibrosis mouse.

Authors:  Robert C De Lisle; Racquel Mueller; Megan Boyd
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-10       Impact factor: 2.839

6.  Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes.

Authors:  Marijke Proesmans; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2003-09-17       Impact factor: 3.183

Review 7.  The cystic fibrosis of exocrine pancreas.

Authors:  Michael Wilschanski; Ivana Novak
Journal:  Cold Spring Harb Perspect Med       Date:  2013-05-01       Impact factor: 6.915

Review 8.  The cystic fibrosis intestine.

Authors:  Robert C De Lisle; Drucy Borowitz
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

9.  Bioelectric characterization of epithelia from neonatal CFTR knockout ferrets.

Authors:  John T Fisher; Scott R Tyler; Yulong Zhang; Ben J Lee; Xiaoming Liu; Xingshen Sun; Hongshu Sui; Bo Liang; Meihui Luo; Weiliang Xie; Yaling Yi; Weihong Zhou; Yi Song; Nicholas Keiser; Kai Wang; Hugo R de Jonge; John F Engelhardt
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

Review 10.  Choline in cystic fibrosis: relations to pancreas insufficiency, enterohepatic cycle, PEMT and intestinal microbiota.

Authors:  Wolfgang Bernhard
Journal:  Eur J Nutr       Date:  2020-08-14       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.